Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Richeldi, Luca
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. [electronic resource] - The New England journal of medicine Sep 2011 - 1079-87 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1103690 doi
Adult
Aged
Alanine Transaminase--blood
Aspartate Aminotransferases--blood
Enzyme Inhibitors--adverse effects
Female
Humans
Idiopathic Pulmonary Fibrosis--drug therapy
Indoles--adverse effects
Liver--drug effects
Male
Middle Aged
Protein-Tyrosine Kinases--antagonists & inhibitors
Vital Capacity
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. [electronic resource] - The New England journal of medicine Sep 2011 - 1079-87 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa1103690 doi
Adult
Aged
Alanine Transaminase--blood
Aspartate Aminotransferases--blood
Enzyme Inhibitors--adverse effects
Female
Humans
Idiopathic Pulmonary Fibrosis--drug therapy
Indoles--adverse effects
Liver--drug effects
Male
Middle Aged
Protein-Tyrosine Kinases--antagonists & inhibitors
Vital Capacity